Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Sell

Analyst Rating

Sell

Simple Moving Average

Sell

Exponential Moving Average

Sell

Relative Strength Index

Neutral

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Nkarta, Inc. Common Stock (NKTX)

Pharmaceutical Preparations

https://www.nkartatx.com

Nkarta Inc is a biopharmaceutical company engaged in developing engineered natural killer (NK) cells to treat cancer. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of tumor targets, and improve persistence for sustained activity in the body for the treatment of cancer. The Company's operations are based in South San Francisco, California.

1150 VETERANS BOULEVARD
SOUTH SAN FRANCISCO, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

07/10/2020

Market Cap

358,791,498

Shares Outstanding

49,070,000

Weighted SO

49,072,342

Total Employees

N/A

Upcoming Earnings

08/08/2024

Beta

0.8410

Last Div

0.0000

Range

1.28-16.24

Chg

0.0750

Avg Vol

725041

Mkt Cap

358791498

Exch

NASDAQ

Country

US

Phone

415 582 4923

DCF Diff

6.0940

DCF

-1.1690

Div Yield

0.0000

P/S

34.0345

EV Multiple

-2.7122

P/FV

0.8247

Div Yield %

0.0000

P/E

-3.4633

PEG

-0.2791

Payout

0.0000

Current Ratio

15.9052

Quick Ratio

15.9052

Cash Ratio

5.7714

DSO

72.7092

DIO

0.0000

Op Cycle

72.7092

DPO

147.6792

CCC

-74.9701

Gross Margin

0.1175

Op Margin

-11.7583

Pretax Margin

-10.2362

Net Margin

-10.2362

Eff Tax Rate

-0.0650

ROA

-0.1948

ROE

-0.2883

ROCE

-0.2325

NI/EBT

1.0000

EBT/EBIT

0.8706

EBIT/Rev

-11.7583

Debt Ratio

0.1544

D/E

0.1888

LT Debt/Cap

0.1501

Total Debt/Cap

0.1588

Int Coverage

-35.4362

CF/Debt

-1.0988

Equity Multi

1.2227

Rec Turnover

5.0200

Pay Turnover

2.4716

Inv Turnover

0.0000

FA Turnover

0.0902

Asset Turnover

0.0190

OCF/Share

-1.2794

FCF/Share

-1.4906

Cash/Share

4.4197

OCF/Sales

-8.9195

FCF/OCF

1.1651

CF Coverage

-1.0988

ST Coverage

-16.9973

CapEx Coverage

-6.0566

Div&CapEx Cov

-6.0566

P/BV

0.8247

P/B

0.8247

P/S

34.0345

P/E

-3.4633

P/FCF

-3.2750

P/OCF

-3.9745

P/CF

-3.9745

PEG

-0.2791

P/S

34.0345

EV Multiple

-2.7122

P/FV

0.8247

DPS

0.0000

Latest Headlines (EST)

Revenue Product Segmentation